Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Z Gastroenterol ; 49(6): 713-9, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21638237

RESUMEN

In virtually all cells including hepatocytes cell volume regulation is accomplished during cell swelling by cellular ion release (activation of K (+) channels and/or anion channels, KCl-cotransport, parallel activation of K (+)/H (+) exchange and Cl (-)/HCO (3)(-) exchange) and following cell shrinkage by cellular ion uptake (activation of Na (+), K (+), 2Cl (-) cotransport, Na (+)/H (+) exchange in parallel to Cl (-)/HCO (3)(-) exchange and Na (+)-channels). Moreover, cell shrinkage triggers the cellular accumulation of organic osmolytes (e. g., myoinositol, betaine, phosphorylcholine, taurine). Cell volume is a powerful regulator of hepatic metabolism. Cell shrinkage stimulates and cell swelling inhibits proteolysis and glycogenolysis. Moreover, cell volume influences the generation of and sensitivity to oxidants. Cell volume regulatory mechanisms furthermore do play a role in fibrosing disease. Kinases stimulating cell volume regulatory mechanisms include the serum and glucocorticoid inducible kinase SGK1, which is expressed in the liver, is genomically up-regulated by cell shrinkage, stimulates a wide variety of channels and transporters including Na (+), K (+), 2Cl (-) cotransport and Na (+)/H (+) exchange and is known to participate in the stimulation of fibrosis. Accordingly, excessive SGK1 expression is observed in liver cirrhosis. The case is made that SGK1 participates in the regulation of liver cell volume and thus in the regulation of hepatic metabolism.


Asunto(s)
Tamaño de la Célula , Hepatocitos/citología , Hepatocitos/fisiología , Proteínas Inmediatas-Precoces/metabolismo , Hígado/citología , Hígado/metabolismo , Modelos Biológicos , Proteínas Serina-Treonina Quinasas/metabolismo , Equilibrio Hidroelectrolítico/fisiología , Animales , Humanos
2.
Acta Physiol (Oxf) ; 200(1): 75-85, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20236253

RESUMEN

AIM: The protein kinase B (PKB)/Akt is known to stimulate the cellular uptake of glucose and amino acids. The kinase is expressed in proximal renal tubules. The present study explored the influence of Akt/PKB on renal tubular phosphate transport. METHODS: The renal phosphate transporter NaPi-IIa was expressed in Xenopus oocytes with or without PKB/Akt and Na(+) phosphate cotransport determined using dual electrode voltage clamp. Renal phosphate excretion was determined in Akt2/PKBbeta knockout mice (akt2(-/-)) and corresponding wild-type mice (akt2(+/+)). Transporter protein abundance was determined using Western blotting and phosphate transport by (32)P uptake into brush border membrane vesicles. RESULTS: The phosphate-induced current in NaPi-IIa-expressing Xenopus oocytes was significantly increased by the coexpression of Akt/PKB. Phosphate excretion [micromol per 24 h per g BW] was higher by 91% in akt2(-/-) than in akt2(+/+) mice. The phosphaturia of akt2(-/-) mice occurred despite normal transport activity and expression of the renal phosphate transporters NaPi-IIa, NaPi-IIc and Pit2 in the brush border membrane, a significantly decreased plasma PTH concentration (by 46%) and a significantly enhanced plasma 1,25-dihydroxyvitamin D(3) concentration (by 46%). Moreover, fractional renal Ca(2+) excretion was significantly enhanced (by 53%) and bone density significantly reduced (by 11%) in akt2(-/-) mice. CONCLUSIONS: Akt2/PKBbeta plays a role in the acute regulation of renal phosphate transport and thus contributes to the maintenance of phosphate balance and adequate mineralization of bone.


Asunto(s)
Túbulos Renales/enzimología , Fosfatos/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , Proteínas Cotransportadoras de Sodio-Fosfato de Tipo IIa/metabolismo , Animales , Transporte Biológico , Biomarcadores/sangre , Biomarcadores/orina , Western Blotting , Calcificación Fisiológica , Calcitriol/sangre , Femenino , Homeostasis , Hipofosfatemia Familiar/enzimología , Hipofosfatemia Familiar/genética , Masculino , Potenciales de la Membrana , Ratones , Ratones Noqueados , Microvellosidades/enzimología , Hormona Paratiroidea/sangre , Técnicas de Placa-Clamp , Proteínas Proto-Oncogénicas c-akt/deficiencia , Proteínas Proto-Oncogénicas c-akt/genética , Ratas , Sodio/metabolismo , Proteínas Cotransportadoras de Sodio-Fosfato de Tipo IIa/genética , Xenopus
3.
Pharmazie ; 60(4): 294-7, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15881611

RESUMEN

Reserpine, an alkaloid from Rauwolfia serpentina was widely used for its antihypertensive action in the past. In the present investigation, reserpine methiodide (RMI), a quaternary analogue of reserpine was synthesised and evaluated biochemically for its central and peripheral amine depleting actions in rats and compared with reserpine. The 24 h urinary excretion of vanillylmandelic acid (VMA), 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA), the respective metabolites of noradrenaline, serotonin and dopamine were estimated and considered as indirect biochemical indices for the amine depleting action of reserpine and RMI. The results indicate that RMI at doses of equal to and double the equimolar doses of reserpine was found to deplete the peripheral amines without affecting the central stores of the amines. The results further suggest that the quaternization of reserpine might restrict its transfer across the blood-brain barrier and could be the reason for its selective peripheral action.


Asunto(s)
Antihipertensivos/farmacología , Antipsicóticos/farmacología , Aminas Biogénicas/metabolismo , Yoduros/farmacología , Reserpina/farmacología , Animales , Cromatografía Líquida de Alta Presión , Dopamina/análisis , Femenino , Ácido Homovanílico/orina , Ácido Hidroxiindolacético/orina , Masculino , Norepinefrina/metabolismo , Ratas , Serotonina/metabolismo , Ácido Vanilmandélico/orina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA